StockData
Evaxion A/S logo

Evaxion A/S (EVAX) stock

EVAXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 2/30
$2.78+0.01 (+0.36%)

Close on Nov 17, 2026Market cap $23.19MP/E –Yield –

Evaxion A/S price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Evaxion A/S's price to sales ratio was 2.5× on Nov 11, 2026, against 1.9× a year earlier. Over the last 3 years it ranged from 0.5× to 156.2×, with a median of 3.4×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.5×+0.9
2025Dec 31, 20251.5×−30.1
2024Dec 31, 202431.7×–

More Evaxion A/S figures

See a number that looks wrong?